Short Answer: Essilor Stellest received FDA market authorization in September 2025, the first spectacle lens cleared in the US to slow pediatric myopia. In the two-year US trial behind that clearance, it cut myopia progression by 71% and axial elongation by 53% versus single-vision lenses. Transitions GEN S photochromics still darken in under 25 seconds. Freeform digital surfacing holds prescription accuracy to 0.01 diopter, ten times finer than conventional surfacing. Meta and EssilorLuxottica sold more than 7 million Ray-Ban and Oakley AI glasses in 2025 and added a display-equipped model in September. Liquid-crystal autofocus lenses for prescription use are now projected for 2027, a year later than earlier estimates.
Technology Maturity at a Glance
| Technology | Status | Key Specification | Impact for Opticians | Timeline |
|---|---|---|---|---|
| Transitions GEN S photochromics | Shipping now | Darkens in ≤25 s, fades in <2 min | Upsell to patients who drive | Available. |
| Essilor Stellest myopia control | Shipping now; FDA-authorized Sept 2025 | 71% less progression, 53% less axial elongation vs. single-vision (2-yr US trial) | First FDA-cleared myopia-control spectacle lens | Available. |
| Hoya MiYOSMART myopia control | Shipping now | 12M+ lenses sold in 40+ countries since 2018; reimbursed in France since July 2025 | Watch for reimbursement to spread past France | Available. |
| Freeform digital progressive lenses | Shipping now | 0.01 diopter accuracy (10× conventional) | Reduces adaptation failures | Available. |
| Ray-Ban Meta AI glasses (Gen 2) | Shipping now | 12 MP cam, 32 GB, 3–4 h active | Customer education opportunity | Available. |
| Ray-Ban Meta Display | Shipping now in the US (since Sept 2025) | Built-in 600×600 px display, 12 MP cam, ≤6 h active / 30 h with case | New Rx-compatible display category to learn | Available; Canada, France, Italy, UK next. |
| Digital PD/SH measurement tools | Shipping now | ±0.5 mm accuracy via photograph | Reduces remakes, enables remote sales | Available. |
| Apple Vision Pro + ZEISS optical inserts | Shipping now (limited scripts) | M5 chip refresh Oct 2025; some prescriptions still unsupported | Niche fitting opportunity | Available (partial). |
| Electrochromic tint-control sunglasses | Shipping as a consumer product (non-Rx) | ~1 s tint change via touch control | Not yet ophthalmic/Rx grade | 2026. |
| Liquid-crystal autofocus spectacles | Niche in VR/camera optics; ophthalmic version still uncertified | Switchable focal power | Will challenge progressive lens design | 2027 estimated. |
| 3D-printed acetate-finish frames | Prototype / limited production | ~30% lighter than acetate | Watch for hybrids in premium segment | 2026–2027. |
Adaptive Lenses: What Has Changed Recently
Photochromic Speed Is No Longer a Compromise
The consistent complaint patients had about photochromic lenses was slow fade-back while driving. Transitions GEN S addresses this. It darkens in under 25 seconds and fades back in fewer than 2 minutes. It also blocks 100% of UVA/UVB and up to 85% of blue-violet light outdoors. For opticians, this removes the objection that photochromics are impractical for commuters.
For patients who want manual tint control instead of automatic activation, this idea has moved from the lab to retail shelves. POVEC’s C1 electrochromic sunglasses, shown at CES 2026, use automotive-grade electrochromic glass to shift tint in about one second at a touch. The lenses are not prescription glass yet, so this is a non-Rx accessory rather than a dispensing opportunity today. It does confirm that instant electronic tinting now works outside a lab.
Liquid-Crystal Autofocus: Promising, Still Not Here
A bifocal prototype using twin liquid-crystal layers can switch between two focal powers via low voltage. This is relevant for both progressive-lens alternatives and AR display integration. Commercial adaptive LC lenses already ship in camera and VR optics. Ophthalmic versions do not yet have a shipping product: IXI, the most visible startup in this space, told CES 2026 attendees it is targeting a 2027 launch once medical certification and manufacturing (via a partnership with Swiss lab OptiSwiss) are in place, a year later than earlier 2026 estimates. Opticians should watch this space, but should not count on it for current patient consultations.
Freeform Digital Surfacing: The Precision Upgrade That’s Already Here
Freeform digital surfacing is a CNC-controlled manufacturing process. It carves a lens’s prescription curve directly onto the surface, point by point, guided by computer algorithms rather than a single fixed grinding tool. This lets labs combine complex aspheric, atoric, and progressive designs with a wearer’s exact prescription and frame-fitting parameters in one lens.
Conventional lens surfacing operates to 0.1 diopter accuracy. Freeform lenses can be refined to 0.01 diopter (ten times the precision of a standard conventional lens). In practice, this translates to fewer adaptation failures with progressive prescriptions, particularly in patients with higher cylinders or oblique axes.
Freeform surfacing also enables personalization parameters (vertex distance, pantoscopic tilt, and wrap angle) that conventional manufacturing cannot incorporate without compromising optical quality. For opticians fitting patients into wrapped sport frames or large-eye designs, this matters.
Accurate fitting parameters are a prerequisite for freeform lenses to deliver their optical benefit. A mismeasured PD or segment height at the point of ordering negates the precision advantage of the surfacing. See the Optogrid guide on segment height measurement for progressive lenses for fitting procedure details. For a broader look at progressive lens design and patient selection, see the progressive lenses overview.
Myopia Control Lenses: Evidence Is Now Five Years Deep
Essilor Stellest: FDA-Authorized, With Five Years of Data Behind It
Essilor’s highly aspherical lenslet (HAL) design, sold as Stellest, cleared a major US milestone in September 2025. The FDA granted market authorization for Stellest lenses to slow myopia progression in children aged 6 to 12. It is the first spectacle lens authorized for this use in the United States. The two-year US trial behind that authorization showed a 71% reduction in myopia progression (spherical equivalent) and a 53% reduction in axial elongation compared with single-vision lenses.
That US clearance sits on top of longer-running international data. The five-year clinical results for the HAL design are published in the peer-reviewed journal Eye and Vision. The incidence of high myopia (greater than −6.00 D) after five years was 9% in the HAL group versus 38% in the single-vision control group. Mean axial elongation was 0.67 mm in the HAL group versus 1.40 mm in controls, a 52% reduction.
These five-year outcomes come from children who began treatment between ages 8 and 13. No significant treatment-related complications were reported. Between the FDA authorization and five years of international data, the clinical case for recommending lenslet-based myopia control to appropriate pediatric patients is now well-supported on both sides of the Atlantic.
Why Myopia Control Matters at Scale
Research published in Ophthalmology projects that 4,758 million people, 49.8% of the global population, will have myopia by 2050. That’s up from 22.9% in 2000. High myopia (associated with retinal detachment, glaucoma, and macular degeneration) is projected to affect 938 million by 2050, making myopia control lenses one of the most consequential optical product categories for the next generation of patients.
Hoya MiYOSMART: Scale and Growing Reimbursement Recognition
MiYOSMART uses a different mechanism (DIMS: Defocus Incorporated Multiple Segments) and has generated over 90 peer-reviewed publications. More than 12 million MiYOSMART lenses have been purchased by parents in over 40 countries since the product’s 2018 launch. Since July 2025, France has reimbursed MiYOSMART for children aged 5–16 with high or rapidly progressive myopia, the first EU country to do so. As other markets watch, opticians who already offer myopia control lenses will be better positioned when reimbursement expands.
Blue-Light Coatings: The Evidence Is Clear
A Cochrane-grade systematic review finds no meaningful relief of digital eye strain or circadian benefit from blue-filter coatings compared with clear lenses. Opticians asked about blue-light lenses by patients should be accurate: current coatings do not reduce asthenopia or improve sleep. Lighting ergonomics and the 20-20-20 rule remain better-supported advice.
Which Lens Brands Have Recently Improved Their Products
Six manufacturers make most of the prescription lenses opticians dispense: Essilor, ZEISS, Hoya, Rodenstock, Shamir, and Nikon. Each has shipped or presented verifiable new lens technology in the last 12 to 18 months.
| Brand | Recent Development | What Changed | Date |
|---|---|---|---|
| Essilor | Stellest FDA market authorization | First US-cleared myopia-control spectacle lens; 71% less progression, 53% less axial elongation vs. single-vision (2-yr trial) | Sept 2025. |
| ZEISS | MyoCare / MyoCare S clinical data at ARVO 2025 | Two-year Asian trial: 0.44 D and 0.20 mm reduction in progression and axial length vs. single-vision (MyoCare); one-year European trial: 0.21 D and 0.14 mm reduction | 2025. |
| Hoya | MiYOSMART reaches 12M+ lenses sold | Over 40 countries since 2018; France reimbursement began | 2025. |
| Rodenstock | B.I.G. EXACT Sensitive | First lens line built around a Visual Sensitivity Index; up to 42% larger aberration-free zones for sensitive wearers | March 2025. |
| Shamir | Sun Intelligence | AI-driven outdoor lens design addressing changing viewing distances, light conditions, and gaze shifts to digital screens outdoors | June 2026. |
| Nikon | Z Series Single Vision | First single-vision lens using binocular contrast technology adapted from camera MTF analysis, for sharper distance and near vision | Feb 2026. |
Two patterns stand out. First, myopia control is where the most clinically rigorous work is happening: Essilor’s FDA authorization and ZEISS’s ARVO data both give opticians trial-backed numbers to discuss with parents, not just marketing claims. Second, AI-assisted lens personalization (Rodenstock’s Visual Sensitivity Index, Shamir’s Sun Intelligence, Nikon’s binocular contrast modeling) has become the default way manufacturers differentiate premium lenses from standard ones. None of these six is uniformly “best”; each is solving a different fitting problem, so the right recommendation still depends on the patient in front of you.
Smart Frames: A Fast-Growing Fitting Opportunity
The AI glasses category kept accelerating into 2026. Display-less smart glasses (the category Ray-Ban Meta and Oakley Meta belong to) shipped 2.25 million units worldwide in Q1 2026 alone, up 167% year-over-year, according to IDC. That single quarter nearly matched the entire category’s 2.7 million units for all of 2024. IDC forecasts roughly 13.6 million display-less units shipping in 2026, generating about $5.1 billion in revenue.
| Device | Primary Use | Key Specs | Optician Relevance |
|---|---|---|---|
| Ray-Ban Meta (Gen 2) | Hands-free photo/video + AI voice assistant | 12 MP cam, 32 GB, 3–4 h active | Prescription-compatible frames; fitting opportunity. |
| Ray-Ban Meta Display | Built-in heads-up display + AI assistant | 600×600 px display, 12 MP cam, ≤6 h active / 30 h with case, $799 | New display category; requires precise Rx data for the insert. |
| TranscribeGlass | Live subtitles for deaf/hard-of-hearing users | 36 g frame, 8 h battery, phone-based speech-to-text | Accessibility fitting niche. |
| Apple Vision Pro + ZEISS inserts | Spatial computing headset | Custom optical inserts required; not all scripts supported | High-value niche; requires precise Rx data. |
| OrCam MyEye 3 Pro | Text-to-speech and object ID for low vision | Clip-on; reads print, recognizes faces and objects | Low vision rehabilitation tool. |
| Oakley Meta HSTN / Vanguard | Sport-focused AI frame variant | Same AI platform as Ray-Ban; wrap-fit design | New sport frame fitting use case. |
Sales Momentum and the New Display Category
Combined Ray-Ban Meta and Oakley Meta AI-glasses sales exceeded 7 million units in 2025, according to EssilorLuxottica’s own full-year results. That more than tripled the prior year’s volume. In September 2025, Meta and EssilorLuxottica added a screen to the lineup with Ray-Ban Meta Display, a $799 pair with a built-in heads-up display, launched first in the US with Canada, France, Italy, and the UK to follow.
For optical retailers, this growth represents a real fitting and prescription opportunity. Many buyers of these frames will need prescription inserts or a parallel prescription pair. See the full breakdown of AI glasses models and their lens compatibility in the Óculos com IA guide. For how practices are incorporating AI tools into their workflows more broadly, see AI in optical practices.
Digital Measurement Tools: Accuracy as a Prerequisite for Advanced Optics
Advanced lens technologies (freeform progressives, myopia control lenslets, AR optical inserts) all require accurate fitting measurements to deliver their designed optical benefit. Errors in pupillary distance or segment height translate directly into prescription failures regardless of how sophisticated the lens design is.
A 2024 comparative study found that measurement method significantly affects distance PD results. The mean difference between ruler and pupillometer methods was 0.54 mm, within ISO 16034:2002 tolerance for most patients but clinically relevant for complex prescriptions. Digital photo-based measurement tools offer consistent repeatability. They also let practices serve patients who cannot attend an in-person dispensing appointment, something we’ve seen matter most for practices juggling multiple locations or online orders.
Optogrid’s remote PD measurement approach uses calibrated photographs to measure to ±0.5 mm precision. This removes the practitioner-skill variability inherent in manual ruler methods while enabling remote dispensing workflows. In our own side-by-side comparisons against pupillometer readings, calibrated-photo capture held inside that ±0.5 mm range even when a different staff member captured each photo. This is directly relevant for optical retailers managing online prescription lens sales or multi-location dispensing.
For a complete picture of digital tools that support modern optical practices, see the essential software guide for eyewear retailers, which covers how measurement tools fit alongside inventory, POS, and CRM systems.
Opticians curious how photo-based capture would perform against their current in-house method can try Optogrid’s remote PD and segment height measurement tool free.
Manufacturing: 3D-Printed Frames Move Past the Prototype Stage
3D-printed nylon frames are approximately 30% lighter than acetate and support design-to-delivery cycles of about one week, enabling mass customization at scale. The limitation remains surface finish: injection-molded acetate still produces a superior high-gloss surface for premium fashion frames. Hybrid construction (printed core, polished thermoplastic over-mold) is the near-term solution to watch for 2026–2027.
FAQ: Eyeglasses Technology
What eyeglasses technology is most useful for opticians to know about right now?
The most clinically relevant developments: Essilor Stellest’s FDA authorization and multi-year evidence for myopia control lenses (Stellest, MiYOSMART), freeform digital surfacing for better progressive outcomes, and digital measurement tools that reduce fitting errors. Smart glasses, including the new display-equipped Ray-Ban Meta Display, create a prescription fitting opportunity but require customer education.
Are myopia control lenses worth recommending to patients?
For children aged 6–16 with progressive myopia, yes. Essilor Stellest received FDA market authorization in September 2025, backed by a two-year US trial showing 71% less progression and 53% less axial elongation than single-vision lenses. Five-year international data shows a 9% versus 38% incidence of high myopia in treated versus control children. Hoya MiYOSMART has sold more than 12 million lenses in over 40 countries and now carries reimbursement status in France.
Which lens brands have recently improved their products?
Essilor, ZEISS, Hoya, Rodenstock, Shamir, and Nikon have all shipped or presented new lens technology in the last 12 to 18 months. Essilor’s Stellest gained FDA authorization for myopia control, ZEISS presented new MyoCare clinical data at ARVO 2025, Rodenstock launched a visual-sensitivity-based lens line, Shamir introduced an AI-driven outdoor lens design, and Nikon adapted camera lens contrast technology for single-vision eyeglasses. See the brand-by-brand table above for dates and figures.
Do blue-light blocking lenses reduce eye strain from screens?
Current evidence says no. A systematic review published on PubMed found no meaningful reduction in digital eye strain from blue-filter coatings. Patients concerned about screen fatigue benefit more from display brightness adjustment, ambient lighting, and the 20-20-20 rule (every 20 minutes, look 20 feet away for 20 seconds).
Can Ray-Ban Meta glasses be fitted with prescription lenses?
Yes. Ray-Ban Meta frames accept prescription lenses through select optical labs. Opticians can order compatible prescription inserts or full Rx lenses through standard channels, depending on the frame model. Oakley Meta frames offer additional sport-frame prescription options.
What is freeform lens technology and why does it matter for progressive lens fitting?
Freeform digital surfacing produces lenses at 0.01 diopter precision versus 0.1 diopter for conventional surfacing. It also allows personalized parameters (vertex distance, pantoscopic tilt, wrap angle) to be incorporated into the lens design. For patients adapting to progressives or wearing sport/wrap frames, this reduces distortion and adaptation failures.
When will liquid-crystal autofocus glasses be available for prescription use?
Ophthalmic-grade liquid-crystal autofocus lenses are now projected for commercial availability around 2027, a year later than earlier estimates. The technology already ships in camera and VR optics, but the leading startup in the space, IXI, still needs medical certification and its manufacturing partnership in place before it can ship a prescription product.
What is the accuracy of digital photo-based PD measurement compared to a ruler?
A comparative study found that PD ruler measurements differ from pupillometer readings by a mean of 0.54 mm. Photo-based digital tools calibrated with a reference object achieve ±0.5 mm repeatability, comparable to pupillometer-class accuracy, with the added benefit of remote use and reduced practitioner-skill dependency.
I grew up inside an optical shop. My mother likes to tell how, as a kid, I would watch eyeglasses being assembled, play with the tools, and draw on the back of service order slips. The family business taught me early what a precise measurement and work done right are worth.
I went on to spend more than twenty years as a software engineer, always keeping an eye on the optical world. Optogrid was born where the two meet: digital measurement technology (pupillary distance and fitting heights) built by someone who knows the dispensing counter from the inside.